CINECA IRIS Institutional Research Information System

RIBALDONE, Davide Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.586
EU - Europa 7.686
AS - Asia 4.695
SA - Sud America 831
AF - Africa 268
OC - Oceania 211
Continente sconosciuto - Info sul continente non disponibili 20
Totale 28.297
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.073
IT - Italia 2.393
CN - Cina 1.845
IE - Irlanda 824
SE - Svezia 597
DE - Germania 510
GB - Regno Unito 508
FR - Francia 453
ES - Italia 446
SG - Singapore 409
TR - Turchia 387
VN - Vietnam 373
BR - Brasile 371
IN - India 358
JP - Giappone 349
PL - Polonia 311
CA - Canada 250
UA - Ucraina 246
MX - Messico 219
FI - Finlandia 184
AU - Australia 175
KR - Corea 154
CO - Colombia 149
HK - Hong Kong 148
NL - Olanda 147
AT - Austria 140
ID - Indonesia 140
RU - Federazione Russa 127
BE - Belgio 107
IR - Iran 103
CH - Svizzera 101
EG - Egitto 101
PT - Portogallo 98
CL - Cile 97
TW - Taiwan 91
PE - Perù 85
RO - Romania 85
GR - Grecia 80
AR - Argentina 67
CZ - Repubblica Ceca 61
HU - Ungheria 55
TH - Thailandia 51
DK - Danimarca 50
IL - Israele 49
PK - Pakistan 40
SA - Arabia Saudita 38
NZ - Nuova Zelanda 35
PH - Filippine 30
EC - Ecuador 27
HR - Croazia 26
TN - Tunisia 24
MY - Malesia 23
NO - Norvegia 23
NG - Nigeria 21
KE - Kenya 20
SI - Slovenia 19
ZA - Sudafrica 18
VE - Venezuela 17
ET - Etiopia 16
EU - Europa 16
MA - Marocco 16
PA - Panama 16
BG - Bulgaria 15
IQ - Iraq 15
LT - Lituania 15
BD - Bangladesh 13
GH - Ghana 13
UY - Uruguay 13
AE - Emirati Arabi Uniti 12
EE - Estonia 12
RS - Serbia 11
JO - Giordania 10
SN - Senegal 10
SK - Slovacchia (Repubblica Slovacca) 9
UZ - Uzbekistan 9
CR - Costa Rica 8
DZ - Algeria 8
BA - Bosnia-Erzegovina 7
KW - Kuwait 7
KZ - Kazakistan 6
LB - Libano 6
LV - Lettonia 6
AF - Afghanistan, Repubblica islamica di 5
AL - Albania 4
AP - ???statistics.table.value.countryCode.AP??? 4
CU - Cuba 4
DO - Repubblica Dominicana 4
HN - Honduras 4
PS - Palestinian Territory 4
SD - Sudan 4
BY - Bielorussia 3
GE - Georgia 3
GT - Guatemala 3
LU - Lussemburgo 3
MO - Macao, regione amministrativa speciale della Cina 3
NP - Nepal 3
QA - Qatar 3
TZ - Tanzania 3
BO - Bolivia 2
IS - Islanda 2
Totale 28.258
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.872
Chandler 1.532
Fairfield 1.072
Dublin 808
Ashburn 706
Beijing 604
Redwood City 565
Houston 532
Torino 524
Woodbridge 444
Seattle 401
Wilmington 398
Jacksonville 394
Cambridge 346
Singapore 252
Nyköping 241
Dong Ket 237
Turin 228
Princeton 212
Medford 209
Pisa 201
Villeurbanne 172
Dearborn 145
Warsaw 144
Milan 140
Shanghai 136
Nanjing 113
Rome 109
Boston 104
Vienna 104
Guangzhou 96
Istanbul 96
Hangzhou 94
San Diego 92
New York 85
London 78
Tokyo 70
Helsinki 69
Seoul 69
Santiago 60
Lima 59
Barcelona 57
Madrid 57
Duncan 56
Bogotá 55
Ottawa 52
Washington 52
Wuhan 51
Brussels 49
Boardman 47
Chengdu 47
Lappeenranta 47
Ankara 45
Fremont 45
Upper Marlboro 45
São Paulo 44
Toronto 43
Berlin 42
Medellín 42
Zhengzhou 42
Cairo 41
Norwalk 40
Hong Kong 37
Los Angeles 37
Bologna 35
Hebei 35
Hyderabad 35
Bengaluru 34
Amsterdam 33
Chicago 33
Buenos Aires 32
Jakarta 32
Paris 31
Taipei 31
Hefei 30
Central District 29
Central 28
Athens 27
Jinan 27
Tehran 27
Silver Spring 26
Bangkok 25
Izmir 25
Naples 25
Tainan City 25
Moscow 24
Melbourne 23
Changsha 22
Frankfurt am Main 22
Indore 22
Kunming 22
Phoenix 22
Rochester 21
San Francisco 21
Prague 20
Tianjin 20
Budapest 19
Polska 19
Pune 19
San Mateo 19
Totale 16.826
Salva come PNG Salva come JPEG
Nome #
Serum zonulin in patients with inflammatory bowel disease: a pilot study 1.686
Risk of drug interactions and prescription appropriateness in elderly patients 1.023
Proctitis: a glance beyond inflammatory bowel diseases 950
Glucose breath test and Crohn's disease: Diagnosis of small intestinal bacterial overgrowth and evaluation of therapeutic response 613
Inflammatory Cutaneous Lesions in Inflammatory Bowel Disease Treated With Vedolizumab or Ustekinumab: An ECCO CONFER Multicentre Case Series 578
Eosinophilic colitis: clinical review and 2020 update 495
The gut and the Inflammatory Bowel Diseases inside-out: the extra-intestinal manifestations 476
A randomized, double-blind, placebo-controlled pilot study to evaluate the efficacy and tolerability of a novel oral bioadhesive formulation for the treatment of nonerosive reflux disease-related symptoms 418
ACG Clinical Guideline on Crohn’s Disease: A Point of View from Europe 411
The adherence to the therapy in inflammatory bowel disease: beyond the number of the tablets 324
Management of Helicobacter pylori in Piedmont, Italy 303
Effectiveness and safety of adalimumab biosimilar ABP 501 in Crohn's disease: an observational study 298
Fecal calprotectin: beyond intestinal organic diseases 280
Significant improvement of glycemic control in diabetic patients with HCV infection responding to direct-acting antiviral agents 276
Adalimumab trough levels predict Crohn's disease clinical course 266
Differential diagnosis of pancreatic cysts: A prospective study on the role of intra-cystic glucose concentration 261
Circulating Zonulin is Related to Hepatic Necroinflammation in Patients with Non Alcoholic Fatty Liver Disease 249
Risk factors of suspected spondyloarthritis among inflammatory bowel disease patients 244
Performance of protein induced by vitamin K absence or antagonist-II assessed by chemiluminescence enzyme immunoassay for hepatocellular carcinoma detection: a meta-analysis 242
Gut microbiota and chronic exercise in diabetic patients: not only bacteria 238
Biosimilar CT-P13 in treating ulcerative colitis in the real world 230
Severe ulcerative colitis: predictors of response and algorithm proposal for rescue therapy 225
Vedolizumab for treatment of chronic refractory pouchitis: a systematic review with pool analysis 217
Physiopathology of intestinal barrier and the role of zonulin 205
Risk of incident melanoma in patients with inflammatory disease treated with anti-TNF: the Turin experience 201
Predictors of risk of fracture in inflammatory bowel diseases: a prospective study using FRAX score 200
Prevalence of infectious agents in patients with systemic sclerosis: Defining the control group 197
Helicobacter pylori infection and ischemic heart disease: could experimental data lead to clinical studies? 195
The therapy of chronic pouchitis 190
Bone mineral density at diagnosis of celiac disease and after 1 year of gluten-free diet 182
Management of Pt1 tumours removed by endoscopy during colorectal cancer screening: Outcome and treatment quality indicators 182
Adalimumab versus azathioprine to halt the progression of bowel damage in Crohn’s disease: application of Lémann Index 177
Primary Hypogammaglobulinaemia with Inflammatory Bowel Disease-Like Features: An ECCO CONFER Multicentre Case Series 177
Prevalence of Micronutrient Deficiency in Patients with Morbid Obesity Before Bariatric Surgery: What About Celiac Disease? 176
Dupilumab to target interleukin 4 for inflammatory bowel disease? Hypothesis based on a translational message 174
Is there a link between periampullary diverticula and biliopancreatic disease? An EUS approach to answer the question 173
Food supplements, stress and gastrointestinal diseases 171
AMOXYCILLIN AND METRONIDAZOLE THERAPY FOR HELICOBACTER PYLORI ERADICATION: A 10-YEAR TREND IN TURIN, ITALY 165
2013 update on celiac disease and eosinophilic esophagitis 161
Pediatric epilepsy and psychiatric comorbidity: could celiac disease diagnosis improve the outcome? 161
Bariatric Surgery and Inflammatory Bowel Disease: a Role for Microbiota? 159
Inflammatory bowel disease course in liver transplant versus non-liver transplant patients for primary sclerosing cholangitis: LIVIBD, an IG-IBD study 154
Microscopic colitis in patients with mild duodenal damage: A new clinical and pathological entity ("lymphocytic enterocolitis")? 150
Adnexal localization of crohn’s disease and recurrent massive ovary cysts 150
Analytical and clinical evaluation of a novel assay for anti-HBc IgG measurement in serum of subjects with overt and occult HBV infection 147
Comment on "Advanced Hepatic Fibrosis in Fatty Liver Disease Linked to Hyperplastic Colonic Polyp" 146
Does Helicobacter pylori infection increase the risk of adult-onset asthma? 145
Periodontal health and coronary heart disease: a comment 144
Gastric emptying and related symptoms in patients treated with buspirone, amitriptyline or clebopride: a "real world" study by 13C-octanoic acid breath test 140
Comments on Sulimani et al.: A weekly 35,000 IU vitamin D supplementation improves bone turnover markers in vitamin D deficient Saudi adolescent females 138
Apparent diffusion coefficient and enhancement patterns in MR imaging as markers of severe or moderate ileum inflammation in Crohn's disease 138
Diagnosis of Helicobacter pylori infection: a look into molecular aspects of urea breath test 138
Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care 138
Helicobacter pylori and proton pump inhibitor therapy: One diagnostic method is enough? 135
Comment on Helicobacter pylori seroprevalence and the occurrence and severity of psoriasis 135
Efficacy of infliximab biosimilars in patients with Crohn's disease 135
Real time visualization may be advisable to exclude aspiration in patients undergoing capsule endoscopy examination 134
Endoscopic ultrasound to diagnose pneumatosis cystoides intestinalis (with video) 133
On Inverse Association between Helicobacter pylori Gastritis and Microscopic Colitis: The European Data 133
Helicobacter pyloriinfection and asthma: Is there a direct or an inverse association? A meta-analysis 132
Is Helicobacter pylori the infectious trigger for headache?: A review 132
Response to: Comment on "efficacy of 7-Day and 14-Day Triple Therapy Regimens for the Eradication of Helicobacter pylori: A Comparative Study in a Cohort of Romanian Patients" 131
OC. 12.4 PRIMARY SCLEROSING CHOLANGITIS ASSOCIATED WITH INFLAMMATORY BOWEL DISEASE: ANALYSIS OF INTESTINAL OUTCOME AFTER LIVER TRANSPLANTATION 131
Clinical Response and Changes of Cytokines and Zonulin Levels in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Treated with Bifidobacterium Longum ES1 for 8 or 12 Weeks: A Preliminary Report 130
Targeting IL-10, ZO-1 gene expression and IL-6/STAT-3 trans-signalling by a combination of atorvastatin and mesalazine to enhance anti-inflammatory effects and attenuate progression of oxazolone-induced colitis 129
Outcomes of COVID-19 in 79 patients with IBD in Italy: An IG-IBD study 128
Power Doppler sonography to predict the risk of surgical recurrence of Crohn’s disease 127
How ameliorate the adherence in patients with inflammatory bowel disease? 127
Dual biological therapy with anti-TNF, vedolizumab or ustekinumab in inflammatory bowel disease: a systematic review with pool analysis 127
Use of probiotics in the Helicobacter pylori eradication in Italy: data from the Italian Registry on Helicobacter pylori treatment 127
Helicobacter pylori eradication: poor medical compliance from East to West of the world 126
A Concise History of Thiopurines for Inflammatory Bowel Disease: From Anecdotal Reporting to Treat-to-Target Algorithms 126
V.02.10 AN INNOVATIVE EVALUATION OF PANCREATIC CYSTS BY CONFOCAL LASER ENDOMICROSCOPY AND FIBER OPTIC LIGHTING DIRECT VISUALIZATION SYSTEM 125
Inflammation in gastrointestinal disorders: prevalent socioeconomic factors 124
A 2016 panorama of Helicobacter pylori infection: key messages for clinicians 122
Correlation between Thiopurine S-Methyltransferase Genotype and Adverse Events in Inflammatory Bowel Disease Patients 121
Association Between Gut Permeability and Insulin Resistance: Any Role for Zonulin in Patients with Non-Alcoholic Fatty Liver Disease? 121
How to interpret meta-analysis results 120
Mo1867 ITALIAN REAL-LIFE STUDY EVALUATING THE LONG TERM EFFECTIVENESS OF VEDOLIZUMAB FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE 120
AISF position paper on HCV in immunocompromised patients 119
Mo1920 – Results of Interim Analysis of a Retrospective Igibd Study on Adalimumab Use in Real Practice in Italy: the Real-Life Clinical Effectiveness of Adalimumab in Ulcerative Colitis (REALADA-UC) Study 119
P02.38 | Current practice of Gastroenterologists in the treatment of Helicobacter pylori infection in Italy: data from the Italian Registry on H. pylori treatment 117
Adalimumab Therapy Improves Intestinal Dysbiosis in Crohn's Disease 117
Features of inflammatory bowel disease followed in a second level center in Northern Italy 116
Comment on "Factors Associated with Recurrent Ulcers in Patients with Gastric Surgery after More Than 15 Years: A Cross-Sectional Single-Center Study" 113
Laboratory evidence of Helicobacter species infection in hepatocellular carcinoma 112
Oral Manifestations of Inflammatory Bowel Disease and the Role of Non-Invasive Surrogate Markers of Disease Activity 112
Osteoporosis, osteopenia, and inflammatory bowel disease: lessons from a real‑world study 110
IS THERE A LINK BETWEEN PERIAMPULLARY DIVERTICULA AND BILIOPANCREATIC DISEASES? AN EUS APPROACH TO ANSWER THE QUESTION 109
Role of bowel ultrasound as a predictor of surgical recurrence of Crohn's disease 109
Helicobacter pylori prevalence: Are the data totally reliable? 108
Rifabutin-Based Rescue Therapy for Helicobacter pylori Eradication: A Long-Term Prospective Study in a Large Cohort of Difficult-to-Treat Patients 108
Higher Efficiency of Percutaneous Microwave (MWA) Than Radiofrequency Ablation (RFA) in Achieving Complete Response in Cirrhotic Patients with Early Hepatocellular Carcinoma 108
Benefit of supplements in functional dyspepsia after treatment of Helicobacter pylori 107
Sa1825 ITALIAN REAL-LIFE STUDY EVALUATING THE LONG-TERM EFFECTIVENESS OF VEDOLIZUMAB FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE: THE ELDERLY COHORT 106
COVID-19: a user's guide, status of the art and an original proposal to terminate viral recurrence 105
THE ROLE OF ANTI-IFI16 ANTIBODIES IN THE MANAGEMENT OF INFLAMMATORY BOWEL DISEASES (IBD) 105
P402 Interstitial and granulomatous lung disease in inflammatory bowel disease patients 105
The Effect of Viral Clearance Achieved by Direct-Acting Antiviral Agents on Hepatitis C Virus Positive Patients with Type 2 Diabetes Mellitus: A Word of Caution after the Initial Enthusiasm 105
Prognostic Role of Serum Cytokeratin-19 Fragment (CYFRA 21-1) in Patients with Hepatocellular Carcinoma 103
Totale 20.921
Salva come PNG Salva come JPEG
Categoria #
all - tutte 74.129
article - articoli 0
book - libri 0
conference - conferenze 4.851
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.980
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.313 138 113 67 298 133 268 308 423 462 422 276 405
2020/20214.931 275 435 407 346 379 455 364 300 405 441 408 716
2021/20227.212 377 297 317 374 319 367 1.364 1.170 915 371 699 642
2022/20236.378 499 457 319 518 620 1.131 599 464 738 296 429 308
2023/20244.695 440 504 294 384 463 495 283 467 87 342 398 538
2024/202597 97 0 0 0 0 0 0 0 0 0 0 0
Totale 29.359